{
    "Additional Indicators": [
        {
            "description": "Unfavorable Prognosis",
            "therapy": "NCCN, Consensus, Non-Small Cell Lung Cancer",
            "mutation": "KRASp.G12C Gain-of-function"
        }
    ],
    "Clinical trials": [
        {
            "description": "A Study of VS-6766 v. VS-6766 + Defactinib in Recurrent G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer ",
            "phase": "Phase 2",
            "mutations": [
                "KRAS"
            ]
        },
        {
            "description": "A Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1",
            "phase": "Phase 1/2",
            "mutations": [
                "KRAS",
                "STK11"
            ]
        },
        {
            "description": "First-in-human Study of DRP-104 (Sirpiglenastat) as Single Agent and in Combination With Atezolizumab in Patients With Advanced Solid Tumors. (NCT04471415)",
            "phase": "Phase 1/2",
            "mutations": [
                "NFE2L2",
                "STK11"
            ]
        }
    ],
    "variants of unknown significance": {
        "Somatic": [
            {
                "Gene": "CTNNB1",
                "DNA Alteration": "c.97T>C",
                "GeneMutation": "p.S33C Spliceregionvariant-LOF",
                "VariantAlleleFraction": "1.6%"
            },
            {
                "Gene": "FGFR2",
                "DNA Alteration": "c.1645A>C",
                "GeneMutation": "p.Y375C Spliceregionvariant-LOF",
                "VariantAlleleFraction": "2.25%"
            },
            {
                "Gene": "HDAC2",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.E455fs*7 Nonsense-GOF",
                "VariantAlleleFraction": "5.51%"
            },
            {
                "Gene": "RB1",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.F650S Frameshift-GOF",
                "VariantAlleleFraction": "3.12%"
            },
            {
                "Gene": "NT5C2",
                "DNA Alteration": "c.1100G>A",
                "GeneMutation": "p.R367Q Spliceregionvariant-LOF",
                "VariantAlleleFraction": "6.51%"
            },
            {
                "Gene": "HSD3B1",
                "DNA Alteration": "c.1100=",
                "GeneMutation": "p.T367= Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "1.25%"
            },
            {
                "Gene": "MYO1G",
                "DNA Alteration": "c.145G>A",
                "GeneMutation": "p.V49M Frameshift-GOF",
                "VariantAlleleFraction": "7.29%"
            },
            {
                "Gene": "NTRK1",
                "DNA Alteration": "c.1792C>T",
                "GeneMutation": "p.G607V Spliceregionvariant-LOF",
                "VariantAlleleFraction": "3.6%"
            },
            {
                "Gene": "FGFR3",
                "DNA Alteration": "c.1111A>T",
                "GeneMutation": "p.G380R Frameshift-LOF",
                "VariantAlleleFraction": "9.89%"
            },
            {
                "Gene": "PIK3CA",
                "DNA Alteration": "c.3141T>G",
                "GeneMutation": "p.E542G Spliceregionvariant-LOF",
                "VariantAlleleFraction": "6.39%"
            }
        ],
        "Germline": []
    }
}